Quarterly report [Sections 13 or 15(d)]

Stockholders??? Equity

v3.25.3
Stockholders’ Equity
 9 Months Ended
Sep. 30, 2025
Equity [Abstract]  
Stockholders’ Equity

 

6. Stockholders’ Equity

 

Warrants

 

The Company had warrants to purchase approximately 462,963 shares of the Company’s common stock (the “Series A Warrants”) outstanding as of December 31, 2024. These warrants expired in February 2025 and, as a result, no Series A Warrants were outstanding as of September 30, 2025. The Series A Warrants were immediately exercisable at a price of $33.00 per share of common stock. No Series A Warrants were exercised or forfeited during the three and nine months ended September 30, 2025 and 2024.

 

The Company also has warrants to purchase approximately 800 shares of the Company’s common stock outstanding as of both September 30, 2025 and December 31, 2024. These warrants have an exercise price of $29.09 per share of common stock and expire on July 3, 2026. None of these warrants were exercised or forfeited during the three and nine months ended September 30, 2024.